A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death-Reference-Cited by-同舟云学术

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death

Published:2024-07 Issue:7 Volume:57 Page:1514-1532.e15
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Mannion Jonathan,Gifford Valentina,Bellenie Benjamin,Fernando Winnie,Ramos Garcia Laura,Wilson Rebecca,John Sidonie Wicky,Udainiya Savita,Patin Emmanuel C.,Tiu Crescens,Smith Angel,Goicoechea Maria,Craxton Andrew,Moraes de Vasconcelos Nathalia,Guppy Naomi,Cheung Kwai-Ming J.,Cundy Nicholas J.,Pierrat Olivier,Brennan Alfie,Roumeliotis Theodoros I.,Benstead-Hume Graeme,Alexander John,Muirhead Gareth,Layzell Scott,Lyu Wenxin,Roulstone Victoria,Allen Mark,Baldock Holly,Legrand Arnaud,Gabel Florian,Serrano-Aparicio Natalia,Starling Chris,Guo Hongyan,Upton Jason,Gyrd-Hansen Mads,MacFarlane Marion,Seddon Benedict,Raynaud Florence,Roxanis Ioannis,Harrington Kevin,Haider Syed,Choudhary Jyoti S.,Hoelder Swen,Tenev Tencho,Meier Pascal

Funder

CRUK

NIH

Cancer Research UK

Breast Cancer Now

Publisher

Elsevier BV

Reference102 articles.

1. Origin and physiological roles of inflammation;Medzhitov;Nature,2008

2. Necroptosis and its role in inflammation;Pasparakis;Nature,2015

3. Lifting the innate immune barriers to antitumor immunity;Rothlin;J. Immunother. Cancer,2020

4. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis;Orozco;Cell Death Differ.,2014

5. The two faces of receptor interacting protein kinase-1;Weinlich;Mol. Cell,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RIPK1: Inflamed if you do, inflamed if you don’t;Immunity;2024-07